This archive contains the following articles listed by volume, issue and page number:

INFUSION RELATED ARTICLES

STERILE PREPARATIONS RELATED ARTICLES

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
May/Jun 2025 Pg. 194-201	Microbial Challenge of Stable Compounded Clozapine Suspensions in Plastic Bottles Author(s): Berzy Jessica, Sachedina Hanif, Virji Arif, Gross Jason A, Cull Erica, Walker Scott E
Mar/Apr 2025 Pg. 116-119	New USP Chapters <72> and <86> for Testing Pharmaceuticals for Sterility and Endotoxins Author(s): Ashworth Lisa D
Jan/Feb 2025 Pg. 38-39	Standard Operating Procedure: Calculating the Endotoxin Load in Compounded Sterile Preparations Author(s):
Nov/Dec 2024 Pg. 475-479	Hand and Glove Sanitizing in Sterile Compounding, Part 1 Author(s): Greeson Nicole MH, Mixon William, Huslage Kirk, Stiegel Matthew A, Thomann Wayne R
Sep/Oct 2024 Pg. 358-362	Pharmaceutical Waters Used in Sterile and Nonsterile Compounding Author(s): Allen Loyd V Jr
Sep/Oct 2024 Pg. 383-393	Safer Sterile Compounding: Choosing and Using Disinfectants for the Cleanroom Author(s): Kastango Eric S, Douglass Kate, Patel Kedar, Givehchi Babak, Brister Paul, Postlewaite Jay, Taraban Laura
Jul/Aug 2024 Pg. 298-303	Sterile Basics of Compounding: Repackaging, Part 1 Author(s): Allen Loyd V Jr
May/Jun 2024 Pg. 229-240	Basics of Sterile Compounding: Sterilization Methods in Sterile Product Manufacturing Author(s): Akers Michael J
Mar/Apr 2024 Pg. 120-127	Sterile Filtration Author(s): Akers Michael J
Jan/Feb 2024 Pg. 44-55	Safer Sterile Compounding: Choosing and Using Disinfectants for the Cleanroom Author(s): Kastango Eric S, Douglass Kate, Patel Kedar, Givehchi Babak, Brister Paul, Postlewaite Jay, Taraban Laura
Nov/Dec 2023 Pg. 483-486	Sterile Basics of Compounding: Allowable Endotoxin Levels in Parenteral Preparations Author(s): Allen Loyd V Jr
Nov/Dec 2023 Pg. 491	Hyaluronidase Injection Author(s): Allen Loyd V Jr
Sep/Oct 2023 Pg. 397-409	Basics of Sterile Compounding: Sterile Basics of Compounding Intravenous Admixtures, Part 4: Physicochemical Considerations Author(s): Allen Loyd V Jr
Jul/Aug 2023 Pg. 305-313	Sterile Basics of Compounding: Intravenous Admixture Compounding, Part 3: Preparation Procedures Author(s): Allen Loyd V Jr
May/Jun 2023 Pg. 223-229	Sterile Basics: Intravenous Admixture Compounding, Part 2: Parenteral Vehicle Considerations Author(s): Allen Loyd V Jr
Mar/Apr 2023 Pg. 114-121	Advanced Compounding; How to Investigate Microbiological Excursions at a Sterile Compounding Facility Author(s): Summers Amy
Mar/Apr 2023 Pg. 123-139	Sterile Basics: Intravenous Admixture Compounding, Part 1: Introduction and Overview of the General Guidelines for an Intravenous Admixture Compounding Program, and Compounding Personnel Considerations Author(s): Allen Loyd V Jr
Mar/Apr 2023 Pg. 142	Aminohippurate Sodium 250 mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2023 Pg. 154-159	Extending Practical (In Use) Shelf Life of Oncology Drug Vials Using Spikes Author(s): de Wilde Sofieke, Crul Mirjam, Breukels Oscar
Jan/Feb 2023 Pg. 39-46	Sterile Basics: How to Know if Your Cleanroom Can Consistently Operate Within a State of Control Author(s): Summers Amy, Stephens Pat
Nov/Dec 2022 Pg. 497-504	Sterile Basics of Compounding: Contamination Control Strategies, Part 2 Author(s): Summers Amy
Nov/Dec 2022 Pg. 515	Potassium Alum 1% Bladder Irrigation for Hemorrhagic Cystitis (Low-Medium Risk Compounding) Author(s): Allen Loyd V Jr
Sep/Oct 2022 Pg. 411-418	Sterile Basics of Compounding: Contamination Control Strategies, Part 1 Author(s): Summers Amy
Jul/Aug 2022 Pg. 309-315	Sterile Basics of Compounding: How to Implement a Robust Visual-inspection Program Author(s): Summers Amy
May/Jun 2022 Pg. 211-213	Three Things You Need to Know Right Now Author(s): Brunner Scott
May/Jun 2022 Pg. 219-228	Sterile Basics of Compounding: Particulates in Parenteral Preparations: Sources, Minimization, and Detection Author(s): Allen Loyd V Jr
May/Jun 2022 Pg. 248-254	Physical and Chemical Stability of Pharmaceutical Preparation of Bumetanide and Scopolamine Author(s): Catry Emilie, Colsoul Marie-Louise, Closset Melanie, Hubert Justine, Soumoy Laura, Bihin Benoit, Thiry Emmanuell, Jamart Jacques, Hecq Jean-Daniel, Galanti Laurence
Mar/Apr 2022 Pg. 118-126	Basics of Compounding: Compounding Nonsterile Preparations Using Cyclodextrins Author(s): Allen Loyd V Jr
Mar/Apr 2022 Pg. 129-136	Sterile Basics of Compounding: Methods of Sterilization and Depyrogenation Author(s): Allen Loyd V Jr
Jan/Feb 2022 Pg. 10-17	Pharmacy Student Satisfaction and Perceptions Following a Virtual Sterile Compounding Experience Author(s): Mohammad Insaf, Lobkovich Alison, Nardolillo Joseph, Wilhelm Shelia
Jan/Feb 2022 Pg. 41-49	Sterile Basics: Compounding Sterile Preparations with Cyclodextrins Author(s): Allen Loyd V Jr
Nov/Dec 2021 Pg. 446-462	Microwave Freeze-thaw Technique for Injectable Drugs: A Review Updated from 1980 to 2021 Author(s): Hecq Jean-Daniel, Soumoy Laura, Closset Mélanie, Colsoul Marie-Lise, Jamart Jacques, Galanti Laurence
Nov/Dec 2021 Pg. 491-496	Basics of Sterile Compounding: Intravenous Admixture Preparation, Part 12: United States Pharmacopeia Chapters Referenced in the Current United States Pharmacopeia Chapter <797> Pharmaceutical Compounding -- Sterile Preparations Author(s): Allen Loyd V Jr
Sep/Oct 2021 Pg. 389-395	Quality Control: How to Produce a Well-closed Sealed Vial in a Regulated CGMP Environment: Part 2 Author(s): Higgins Doral (Neal) O, Prudom Melanie J, Summers Amy
Jul/Aug 2021 Pg. 276-281	Expecting the Expected: Planning Considerations for Cleanroom Construction Author(s): Roberts Patricia A, Kroon Laura
Jul/Aug 2021 Pg. 298-302	Quality Control: How to Produce a Well-closed Sealed Vial in a Regulated CGMP Environment: Part 1 Author(s): Higgins Doral (Neal) O, Prudom Melanie J, Summers Amy
Jul/Aug 2021 Pg. 311-317	Basics of Sterile Compounding: Intravenous Admixture Preparation Considerations, Part 10: Packaging and Container-closure Issues Author(s): Allen Loyd V Jr
May/Jun 2021 Pg. 182-186	Pharmacy Technicians' Perceptions of Risk Reduction Strategies Implemented in Response to the Repetitive Strain Injury Associated with Sterile Compounding Author(s): Zamani Mazdak, Chan Kayin, Wilcox Julie
May/Jun 2021 Pg. 222-229	Intravenous Admixture Preparation Considerations, Part 9-B: Error Prevention in Intravenous Admixture Preparation Author(s): Allen Loyd V Jr
Mar/Apr 2021 Pg. 92	PreScription: The Past (-->2020), The Present, and The Future (2021-->) Author(s): Allen Loyd V Jr
Mar/Apr 2021 Pg. 109-113	Descriptive Report of Individual State Responses to Personal Protective Equipment Shortages for Pharmacy Practice During the Covid-10 Pandemic Author(s): Roberts Patricia A, Eberwein Samuel M, Youmans Danielle, Amerine Lindsey B
Mar/Apr 2021 Pg. 131-139	Intravenous Admixture Preparation Considerations, Part 9-A: Error Prevention in Intravenous Admixture Preparation Author(s): Allen Loyd V Jr
Jan/Feb 2021 Pg. 18-23	Reversing Erectile Dysfunction and Urinary Incontinence After Prostatectomy or Radiotherapy: The Stanley Prostate-Cancer Treatment Protocol Author(s): McKettrick Greg, Yoch Doug
Jan/Feb 2021 Pg. 42	Acetaminophen (Paracetamol) 50 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Nov/Dec 2020 Pg. 460-465	Establishing a Structured Pharmacy Training Program in Sterile Compounding Author(s): Dirbas Muhannad, AbuSara Aseel K, Whiyabi Shatha, Harb Rema, Telfah Shorouq
Nov/Dec 2020 Pg. 473-478	Intravenous Admixture Preparation Considerations, Part 7: Stability Issues Author(s): Allen Loyd V Jr
Sep/Oct 2020 Pg. 358-364	Cocamidopropyl Betaine Surfactant 0.075% Solution in Physiological Serum for Hygiene Process of COVID-19 Intubated Patients Author(s): Nogales Luis Marcos, Jiménez Labaig Luis, Abarca Lachén Edgar, Gil Melcón María, López-Nieves Marisol
Sep/Oct 2020 Pg. 406	Ketamine 60.6-mg/mL, Acepromazine 0.6-mg/mL, and Xylazine 6.67-mg/mL Injection (Vet-Rat and Hamster); Ketamine 6.06-mg/mL, Acepromazine 0.06-mg/mL, and Xylazine 0.667-mg/mL Injection (Vet-Mouse) Author(s): Allen Loyd V Jr
Sep/Oct 2020 Pg. 434-438	Evaluation of the Efficacy and Superiority of Different Vial Rubber Closure Disinfection Techniques Author(s): Bjornstad Matthew, Kosinski Tracy, Burlage Robert
Jul/Aug 2020 Pg. 299-303	Quality Control: Rapid Sterility Testing for Compounding Pharmacies Author(s): Taylor Andrew
Jul/Aug 2020 Pg. 305-309	Sterile Basics: Intravenous Admixture Preparation Considerations, Part 5: pH Considerations Author(s): Allen Loyd V Jr
Jul/Aug 2020 Pg. 346-351	Single Center Experience with Robot Technologies for Sterile Compounding: A Retrospective Review Author(s): Milibari Loay, Cotugno Michael, Belisle Caryn, Rocchio Megan, Patterson Robert F, Chacon Pablo, Fanikos John, Vo Peter
May/Jun 2020 Pg. 215-220	Sterile Basics: Intravenous Admixture Preparation Considerations, Part 4: Particulates Author(s): Allen Loyd V Jr
Mar/Apr 2020 Pg. 121-126	Intravenous Admixture Preparation Considerations, Part 3: Methods and Techniques to Decrease Incompatibilities Author(s): Allen Loyd V Jr
Jan/Feb 2020 Pg. 14-19	How to Qualify Container Closure Systems for Intended Use, Part 2: Choosing the Right Components for Container Closure Systems Author(s): Vaughn Stacey R, Radwick Allison
Jan/Feb 2020 Pg. 44-50	Intravenous Admixture Preparation Considerations, Part 2: Incompatibilities and Factors Involved Author(s): Allen Loyd V Jr
Nov/Dec 2019 Pg. 447-452	Primary Engineering Controls in Pharmaceutical Compounding, Part 1: Unidirectional-airflow Workstations, Compounding Aseptic Isolators, and Compounding Aseptic Containment Isolators Author(s): Mulder Kyle
Nov/Dec 2019 Pg. 454-461	How to Qualify Container Closure Systems for Intended Use, Part 1 Author(s): Kim Amy A, Gehrmann Matthew R, McCaw James, McAndrew T Page
Nov/Dec 2019 Pg. 467-471	Quality Control: Hand and Glove Sanitizing in Sterile Compounding, Part 2 Author(s): Greeson Nicole MH, Mixon William, Huslage Kirk, Stiegel Matthew A, Thomann Wayne R
Nov/Dec 2019 Pg. 478-482	Intravenous Admixture Preparation Considerations, Part 1: Overview of Series on Personnel Selection for Intravenous Admixture Compounding Author(s): Allen Loyd V Jr
Sep/Oct 2019 Pg. 387-391	Quality Control: Hand and Glove Sanitizing in Sterile Compounding, Part 1 Author(s): Greeson Nicole MH, Mixon William, Huslage Kirk, Stiegel Matthew A, Thomann Wayne R
Sep/Oct 2019 Pg. 399-402	Sterile Basics: Pharmaceutical Waters Used in Sterile and Nonsterile Compounding Author(s): Allen Loyd V Jr
Jul/Aug 2019 Pg. 299-303	Summary of Quality-Control Testing for Sterile and Nonsterile Compounded Preparations, Part 2: Microbiological Testing Author(s): Allen Loyd V Jr
May/Jun 2019 Pg. 221-228	Basics of Sterile Compounding: Vehicles Used in Sterile Compounding Author(s): Allen Loyd V Jr
May/Jun 2019 Pg. 238-244	Evaluation of the Quality of Sterile Compounding Videos Available on the YouTube Video-sharing Website Author(s): Sluggett Janet K, Johnson Michelle J, Zamani Mazdak, Kastango Eric S, Bodnar Mark, Cantor Peter, Hobbs Jodie G, Reynolds Karen J, Sluggett Andrew J
Mar/Apr 2019 Pg. 123-130	Basics of Compounding for Sterile, Nonsterile, and Quality Control Compounding: Process Analytical Technology: Appropriate for Sterile and Nonsterile Compounding? Author(s): Allen Loyd V Jr
Jan/Feb 2019 Pg. 47-49	Quality Control and Basics of Sterile Compounding: Attempting to Avoid Out-of-Specification Results and Patient Harm in Sterile Compounding Author(s): Martin Matt
Nov/Dec 2018 Pg. 475-478	Basics of Sterile Compounding. Quality Assurance and Quality Control: Being Prepared for U.S. Food and Drug Administration Inspections and Staying in Compliance with United States Pharmacopeia Chapter <797>: Part 2 Author(s): Martin Matt
Sep/Oct 2018 Pg. 387-398	Compounding Enclosures: Ensuring Safety During the Preparation of Sterile and Nonsterile Formulations Author(s): Ashe Krystina, Baskett Dustin
Sep/Oct 2018 Pg. 401-404	Quality Assurance and Quality Control: Being Prepared for U.S. Food and Drug Administration Inspections and Staying in Compliance with United States Pharmacopeia Chapter <797>: Part 1 Author(s): Martin Matt
Sep/Oct 2018 Pg. 408	Cysteamine 0.5% Ophthalmic Solution Author(s): Allen Loyd V Jr
Jul/Aug 2018 Pg. 303-312	Basics of Sterile Compounding: Criteria for Determining Beyond-use Dating Author(s): Martin Matt
May/Jun 2018 Pg. 206-217	Quality Control–Sterile Compounding: Analytical Methods. Density Determinations and Quality Control in Nonsterile and Sterile Compounding Author(s): Allen Loyd V Jr
May/Jun 2018 Pg. 234	Dorzolamide 2% Ophthalmic Solution Author(s): Allen Loyd V Jr
May/Jun 2018 Pg. 237	Rolapitant Injectable Emulsion with Dexamethasone Sodium Phosphate Admixture Author(s): Allen Loyd V Jr
Mar/Apr 2018 Pg. 129-134	Quality Control: Lessons Learned from a Trimix Stability Study in a 503A Compounding Pharmacy Author(s): Rhoads Rick
Mar/Apr 2018 Pg. 147	Dorzolamide 2% and Timolol 0.5% Ophthalmic Solution Author(s): Allen Loyd V Jr
Mar/Apr 2018 Pg. 151	Rolapitant Injectable Emulsion with Palonosetron Hydrochloride Admixture Author(s): Allen Loyd V Jr
Jan/Feb 2018 Pg. 41-46	Sterile Basics of Compounding: Relationship Between Syringe Size and Dosing Accuracy Author(s): Kosinski Tracy M, Brown Michael C, Zavala Pedro J
Jan/Feb 2018 Pg. 50	Glutamate and Aspartate Cardioplegia Additive Solution Author(s): Allen Loyd V Jr
Jan/Feb 2018 Pg. 57	Sodium Citrate 9% Nasal Spray for Olfactory Disorders Author(s): Allen Loyd V Jr
Nov/Dec 2017 Pg. 493	Haloperidol 5-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2017 Pg. 498	Trace Elements Injection 5 Author(s): Allen Loyd V Jr
Nov/Dec 2017 Pg. 499	Vancomycin 5-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2017 Pg. 395-404	Basics of Sterile Compounding: Particulate Matter Author(s): Akers Michael J
Sep/Oct 2017 Pg. 408	Acetylcysteine Solutions for Inhalation Author(s): Allen Loyd V Jr
Sep/Oct 2017 Pg. 410	Etoposide 20-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2017 Pg. 411	Fentanyl Citrate 50-mcg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2017 Pg. 413	Ioversol Injection Author(s): Allen Loyd V Jr
Sep/Oct 2017 Pg. 415	Peritoneal Dialysis Solution with 1.5%, 2.5%, or 4.25% Dextrose Author(s): Allen Loyd V Jr
Sep/Oct 2017 Pg. 416	Tacrolimus 0.3-mg/mL Ophthalmic Solution Author(s): Allen Loyd V Jr
Sep/Oct 2017 Pg. 426-429	Stability of Dalteparin 1,000 Unit/mL in 0.9% Sodium Chloride for Injection in Polypropylene Syringes Author(s): Kirkham Kylian, Munson Jessica M, McCluskey Susan V, Graner Kevin K
Sep/Oct 2017 Pg. 436-439	Stability of Dexmedetomidine in 0.9% Sodium Chloride in Two Types of Intravenous Infusion Bags Author(s): Marquis Kathleen, Hohlfelder Benjamin, Szumita Paul M
Jul/Aug 2017 Pg. 277-280	Component Selection for Sterile Compounding Author(s): Dilzer Richard H
Jul/Aug 2017 Pg. 301-308	Basics of Sterile Compounding: Excipients Used in Injections Author(s): Akers Michael J
Jul/Aug 2017 Pg. 317	Reteplase Injection Author(s): Allen Loyd V Jr
Jul/Aug 2017 Pg. 319	Tacrolimus 0.06% Ophthalmic Drops Author(s): Allen Loyd V Jr
Jul/Aug 2017 Pg. 320	Torsemide 10-mg/mL Injection Author(s): Allen Loyd V Jr
May/Jun 2017 Pg. 182-190	Adventures in the Environmental World and Environmental Microbiology Sampling of Air for Pharmaceutical Sterile Compounding Author(s): Ligugnana Roberto
May/Jun 2017 Pg. 193-203	Microbiologic Testing for 503A Sterile-Compounding Pharmacies Author(s): Mixon William, Roth Abby
May/Jun 2017 Pg. 223-228	Basics of Sterile Compounding: Manipulating Peptides and Proteins Author(s): Akers Michael J
Mar/Apr 2017 Pg. 95-102	U.S. Food and Drug Administration Inspections: Guide to a Successful Outcome for 503A Sterile Compounding Pharmacies Author(s): Yoch Doug
Mar/Apr 2017 Pg. 133-142	Accuracy Considerations in Sterile Compounding Author(s): Akers Michael J
Mar/Apr 2017 Pg. 150-153	Stability of Alprostadil in 0.9% Sodium Chloride Stored in Polyvinyl Chloride Containers Author(s): McCluskey Susan V, Kirkham Kylian, Munson Jessica M
Jan/Feb 2017 Pg. 47-56	Basics of Sterile Compounding: Biopharmaceutics of Injectable Dosage Forms Author(s): Akers Michael J
Jan/Feb 2017 Pg. 62	Infliximab 1% Ophthalmic Solution Author(s): Allen Loyd V Jr
Jan/Feb 2017 Pg. 64	Tetracaine Hydrochloride 0.5% Ophthalmic Solution Author(s): Allen Loyd V Jr
Nov/Dec 2016 Pg. 495-500	Basics of Sterile Compounding: Ophthalmic Preparations, Part 2: Suspensions and Ointments Author(s): Allen Loyd V Jr
Nov/Dec 2016 Pg. 509	Flumazenil 0.1-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2016 Pg. 399-404	Basics of Sterile Compounding: Ophthalmic Preparations, Part 1: Ophthalmic Solutions Author(s): Allen Loyd V Jr
Sep/Oct 2016 Pg. 408	Inamrinone 5-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2016 Pg. 415	Tromethamine Injection Author(s): Allen Loyd V Jr
Jul/Aug 2016 Pg. 283-292	Choosing a Vial Processing Line for Aseptic Compounding: Part 1 Author(s): Noorian Shaun, Vahedi Navid
Jul/Aug 2016 Pg. 307-314	Basics of Sterile Compounding: Personnel Requirements for Sterile Compounding Author(s): Akers Michael J
Jul/Aug 2016 Pg. 318	Dolasetron Mesylate 20-mg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2016 Pg. 319	Gatifloxacin 0.5% Ophthalmic Solution Author(s): Allen Loyd V Jr
Jul/Aug 2016 Pg. 325	Plasmingen and Hyaluronate Sodium Ophthalmic Solution Author(s): Allen Loyd V Jr
Jul/Aug 2016 Pg. 326	Scopolamine Hydrobromide 0.25% Ophthalmic Solution Author(s): Allen Loyd V Jr
May/Jun 2016 Pg. 217-222	Basics of Sterile Compounding: Clinical Hazards of Injectable Drug Administration Author(s): Akers Michael J
May/Jun 2016 Pg. 226	Carboplatin 50-mg/mL Injection Author(s): Allen Loyd V Jr
May/Jun 2016 Pg. 227	Cefotetan Disodium Injection Author(s): Allen Loyd V Jr
May/Jun 2016 Pg. 228	Dexamethasone 0.1%, Neomycin 0.35%, and Polymixin 10,000 Units/g Ophthalmic Ointment Author(s): Allen Loyd V Jr
May/Jun 2016 Pg. 234	Sodium Nitroprusside 25-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2016 Pg. 99-104	Root Cause Analysis, Part 2: Sterile Compounding Author(s): Cabaleiro Joe, Jackson Kathleen
Jan/Feb 2016 Pg. 41-45	Formulation and Stability of Solutions Author(s): Akers Michael J
Jan/Feb 2016 Pg. 51	Dexamethasone, Neomycin, and Polymyxin Ophthalmic Ointment Author(s): Allen Loyd V Jr
Jan/Feb 2016 Pg. 54	Thrombin 1,000 Units/mL Topical Solution, Sterile Author(s): Allen Loyd V Jr
Jan/Feb 2016 Pg. 55	Tropicamide 1% Ophthalmic Solution Author(s): Allen Loyd V Jr
Jan/Feb 2016 Pg. 56	Vancomycin 5% and Amikacin 2% Ophthalmic Solution Author(s): Allen Loyd V Jr
Nov/Dec 2015 Pg. 491-500	Basics of Sterile Compounding: Sterile Product Packaging and Delivery Systems Author(s): Akers Michael J
Nov/Dec 2015 Pg. 505	Cefepime Hydrochloride 100-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2015 Pg. 506	Cefotaxime 100-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2015 Pg. 507	Chlorpromazine Hydrochloride 25-mg/mL Injection, Preserved Author(s): Allen Loyd V Jr
Nov/Dec 2015 Pg. 509	Estradiol Valerate 40-mg/mL in Oil Injection Author(s): Allen Loyd V Jr
Nov/Dec 2015 Pg. 510	Levetiracetam 100-mg/mL Injection (Concentrate) Author(s): Allen Loyd V Jr
Sep/Oct 2015 Pg. 383-386	Using Hospital Laboratory Services to Perform Quality-control Testing on Compounded Preparations Author(s): Donnelly Ronald F
Sep/Oct 2015 Pg. 393-401	Sterile Filtration Author(s): Akers Michael J
Jul/Aug 2015 Pg. 268-278	Safer Sterile Compounding: Choosing and Using Disinfectants for the Cleanroom Author(s): Kastango Eric S, Douglass Kate, Patel Kedar, Givehchi Babak, Brister Paul, Postlewaite Jay, Taraban Laura
Jul/Aug 2015 Pg. 315-320	Basics of Sterile Compounding: Barrier Isolator Technologist in Aseptic Processing Author(s): Akers Michael J
Jul/Aug 2015 Pg. 324	Ammonium Molybdate 25-mcg/mL Injection Author(s): Allen Loyd V
Jul/Aug 2015 Pg. 328	Cytarabine 50-mg/mL Injection Author(s): Allen Loyd V
Jul/Aug 2015 Pg. 329	Moxifloxacin Hydrochloride 1.6-mg/mL Intravenous Injection Author(s): Allen Loyd V
Jul/Aug 2015 Pg. 330	Oxytocin 10-units/mL Injection Author(s): Allen Loyd V
Jul/Aug 2015 Pg. 331	Phytonadione 2-mg/mL Injection Author(s): Allen Loyd V
May/Jun 2015 Pg. 182-192	Dry-heat Depyrogenation Ovens for Pharmaceutical Compounding Facilities Author(s): Weller Tom, Kragseth Rolf, Dullinger Roger, Illum Henrik, Perry Alan
May/Jun 2015 Pg. 215-221	Quality Assurance and Quality Control, Part 2 Author(s): Akers Michael J
May/Jun 2015 Pg. 232-238	Basics of Sterile Compounding: Contamination Control Author(s): Akers Michael J
May/Jun 2015 Pg. 246	Physostigmine Salicylate 1-mg/mL Injection Author(s): Allen Loyd V Jr
May/Jun 2015 Pg. 247	Scopolamine Hydrobromide -.4-mg/mL Injection Author(s): Allen Loyd V Jr
May/Jun 2015 Pg. 252-260	Protocol of Blood Serum Eye Drops Author(s): Katsakoulas Ioannis, Lougovoi Claudia, Paraskevopoulou Penelope, Vougioukas Nikolaos
May/Jun 2015 Pg. 261-267	Physico-chemical Stability of MabThera Drug-product Solution for Subcutaneous Injection under In-use Conditions with Different Administration Materials Author(s): Mueller Claudia, Dietel Elde, Heynen Severin R, Nalenz Heiko, Goldbach Pierre, Mahler Hanns-Christian, Schmidt Johannes, Grauschopf Ulla, Schoenhammer Karin
Mar/Apr 2015 Pg. 94-102	New England Compounding Center Indictment Author(s): Cabaleiro Joe
Mar/Apr 2015 Pg. 121-124	Quality Assurance and Quality Control, Part 1 Author(s): Akers Michael J
Mar/Apr 2015 Pg. 127-138	Basics of Sterile Compounding: Sterilization Methods in Sterile Product Manufacturing Author(s): Akers Michael J
Mar/Apr 2015 Pg. 143	Aminohippurate Sodium 200-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2015 Pg. 146	L-Cysteine Hydrochloride 50-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2015 Pg. 147	Morrhuate Sodium 5% Injection Author(s): Allen Loyd V Jr
Mar/Apr 2015 Pg. 149	Pancuronium Bromide 1-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2015 Pg. 150	Physostigmine Salicylate 1-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2015 Pg. 151	Trypan Blue 0.06% Ophthalmic Solution Author(s): Allen Loyd V Jr
Jan/Feb 2015 Pg. 49-56	Basics of Sterile Compounding: Aseptic Processing Author(s): Akers Michael J
Jan/Feb 2015 Pg. 62	Cisplatin 1-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2015 Pg. 63	Daunorubicin 5-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2015 Pg. 64	Erythromycin 50-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2015 Pg. 65	Hydralazine Hydrochloride 20-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2015 Pg. 69	Phentolamine Mesylate 5-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2014 Pg. 444	PreScription: "Named Formulas" Database Available Author(s): Allen Loyd V Jr
Nov/Dec 2014 Pg. 446-454	Depyrogenation Options for the Compounding Cleanroom Author(s): Weller Tom, Bell Jeff, Dullinger Roger, Allen Vern, Anthenat Bruce
Nov/Dec 2014 Pg. 479-484	Basics of Compounding: Unique and Special Characteristics of Sterile Dosage Forms Author(s): Akers Michael J
Nov/Dec 2014 Pg. 495	Dexmedetomidine 100 mcg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2014 Pg. 497	Leucovorin 10-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2014 Pg. 498	Levocarnitine 200-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2014 Pg. 500	Methylene Blue 10-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2014 Pg. 502	Oxacillin Sodium 167-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2014 Pg. 358-364	Roboticized Compounding of Oncology Drugs in a Hospital Pharmacy Author(s): Palma Elisabetta, Bufarini Celestino
Sep/Oct 2014 Pg. 397-399	Basics of Compounding: Certification of Sterile Equipment and Facilities: What Pharmacists Need to Know Author(s): Lanze Amanda, Rudner Shara
Sep/Oct 2014 Pg. 408	Azithromycin 100-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2014 Pg. 410	Dexpanthenol 250-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2014 Pg. 411	Ephedrine Sulfate 50-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2014 Pg. 412	Fluorescein 100-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2014 Pg. 413	Indocyanine green 2.5-mg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2014 Pg. 270-276	Vial Washers for the Compounding Pharmacy: Ensuring Preparation Safety Author(s): Johnson Kain, Sully Andrew, Anthenat Bruce
Jul/Aug 2014 Pg. 313-317	Basics of Compounding Sterile Preparations: Nomenclature and Considerations Author(s): Allen Loyd V Jr
Jul/Aug 2014 Pg. 322	Atracurium Besylate 10-mg/mL Injection, Preserved Author(s): Allen Loyd V Jr
Jul/Aug 2014 Pg. 324	Calcitriol 1-mcg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2014 Pg. 325	Chloramphenicol 100-mg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2014 Pg. 329	Indigo Carmine Injection Author(s): Allen Loyd V Jr
Jul/Aug 2014 Pg. 330	Propranolol Hydrochloride 1-mg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2014 Pg. 331	Zinc 1-mg/mL Injection Author(s): Allen Loyd V Jr
May/Jun 2014 Pg. 234	Bupivacaine Hydrochloride 0.5% Injection Author(s): Allen Loyd V Jr
May/Jun 2014 Pg. 237	Lidocaine Hydrochloride 1% Injection Author(s): Allen Loyd V Jr
Mar/Apr 2014 Pg. 94-99	A Needle-free Reconstitution and Transfer System for Compounded Sterile Intravenous Drug Solutions: In Compliance with United States Pharmacopeia Chapter <797> Standards Author(s): Marks Zach
Mar/Apr 2014 Pg. 123-130	Quality Control Analytical Methods: The Essentials of United States Pharmacopeia Chapter <51> Antimicrobial Effectiveness Testing and Its Application in Pharmaceutical Compounding Author(s): Vu Nicole, Nguyen Devin, Kupiec Thomas C
Mar/Apr 2014 Pg. 131-134	Basics of Sterile Compounding: Compounding by Weight Versus Compounding by Volume Author(s): Allen Loyd V Jr
Mar/Apr 2014 Pg. 143	Fludarabine Phosphate 25-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2014 Pg. 144	Mecasermin 10-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2014 Pg. 145	Methylprednisolone 40-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2014 Pg. 146	Polymixin B Injection Author(s): Allen Loyd V Jr
Mar/Apr 2014 Pg. 147	Rocuronium Bromide 10-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2014 Pg. 149	Selenium 40-mcg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2014 Pg. 150	Sincalide 1-mcg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2014 Pg. 151	Testosterone Enanthate 200-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2014 Pg. 6-12	The Role of Compounding in Closing Therapeutic Gaps--Abstracts from FIP 2013 Author(s): Lutz Eugene, Pauletti Giovanni, Carvalho Maria, Davidson Gigi, Ashworth Lisa, Subramaniam Vaiyapuri, Llambí Francesc
Jan/Feb 2014 Pg. 30-34	Determination of Risk for Sterile Preparations Author(s): Freedman ben-Horin Shimon, Rousso Tamaro
Jan/Feb 2014 Pg. 46-52	Quality Control Analytical Methods: Laboratory Considerations of United States Pharmacopeia Chapter <71> Sterile Tests and Its Application to Pharmaceutical Compounding Author(s): Hyde Tiffany D
Jan/Feb 2014 Pg. 54-57	Basics of Sterile Compounding: Bubble Point Testing Author(s): Thoma Laura
Jan/Feb 2014 Pg. 60	Aztreonam Injection Author(s): Allen Loyd V Jr
Jan/Feb 2014 Pg. 61	Bumetanide 0.25-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2014 Pg. 62	Droperidol 2.5-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2014 Pg. 67	Potassium Chloride 2-mEq/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2014 Pg. 68	Procainamide Hydrochloride 100-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2014 Pg. 69	Vasopressin 20-units/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2013 Pg. 465-475	Improving the Review of Standard Operating Procedures: A Novel Electronic System for Compounding Pharmacies Author(s): Brensel Robert, Brensel Scott, Ng Amy
Nov/Dec 2013 Pg. 498	Benztropine Mesylate 1-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2013 Pg. 499	Cefazolin 250-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2013 Pg. 502	Cyclopentolate Hydrochloride 0.2% and Phenylephrine Hydrochloride 1% Ophthalmic Solution Author(s): Allen Loyd V Jr
Nov/Dec 2013 Pg. 503	Dihydroergotamine Mesylate 1-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2013 Pg. 358-362	Compounding Pharmacies: Before and After an Inspection Author(s): Kulkarni Darshan, Ricketts Samantha
Sep/Oct 2013 Pg. 414	Acyclovir 50-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2013 Pg. 415	Aminocaproic Acid 250-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2013 Pg. 416	Clindamycin 150-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2013 Pg. 417	Fluorouracil 50-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2013 Pg. 418	Hydroxyzine Hydrochloride 25-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2013 Pg. 419	Indomethacin 1-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2013 Pg. 420	Mesna 100-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2013 Pg. 421	Methotrexate 25-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2013 Pg. 422	Phenylephrine Hydrochloride 10-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2013 Pg. 423	Terbutaline Sulfate 1-mg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2013 Pg. 283-288	United States Pharmacopeia Chapter <797> Timeline: 1989 to 2013 Author(s): Newton David W
Jul/Aug 2013 Pg. 307-311	Quality Control Analytical Methods: End-preparation Assessments and Tests for Compounded Sterile Preparations Author(s): McElhiney Linda F
Jul/Aug 2013 Pg. 328	Allopurinol Sodium 4-mg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2013 Pg. 329	Amikacin Sulfate 250-mg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2013 Pg. 330	Dacarbazine 200-mg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2013 Pg. 331	Ketamine 50-mg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2013 Pg. 332	Methohexital Sodium 500-mg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2013 Pg. 333	Metoprolol Tartrate 1-mg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2013 Pg. 335	Succinylcholine Chloride 50-mg/mL Injection Author(s): Allen Loyd V Jr
May/Jun 2013 Pg. 193-199	Decontamination Technology: The Missing Element Author(s): Rahe Hank
May/Jun 2013 Pg. 238-246	Assessing the Stability of Common Radiopharmaceuticals Compounded and Utilized Outside Package Insert Guidelines Author(s): Weatherman Kara D, Augustine Samuel, Christoff Jeffrey, Galbraith Wendy
Mar/Apr 2013 Pg. 94-98	Sterilization of Compounded Parenteral Products: Verification of Autoclaves Author(s): Rahe Hank
Mar/Apr 2013 Pg. 130-134	Quality Control Analytical Methods: Strategies to Ensure a Robust Quality-control Microbiology Program Author(s): Griffiths Tricia, Connors Anne
Mar/Apr 2013 Pg. 136-140	Basics of Compounding: Repackaging, Part 2 Author(s): Allen Loyd V Jr
Mar/Apr 2013 Pg. 144	Adenosine 3-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2013 Pg. 145	Alcohol Dehydrated Injection Author(s): Allen Loyd V Jr
Mar/Apr 2013 Pg. 147	Ciprofloxacin 10-mg/mL Intravenous Injection Concentrate Author(s): Allen Loyd V Jr
Mar/Apr 2013 Pg. 148	Cyanocobalamin 1000-mcg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2013 Pg. 149	Dexrazoxane 1-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2013 Pg. 150	Meropenem 50-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2013 Pg. 151	Paclitaxel 6-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2013 Pg. 152	Thiotepa 15-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2013 Pg. 168-174	Establishing Benchmark Rates of Microbial and Bacterial Endotoxin Contamination for Radiopharmaceuticals Compounded in Commerical Nuclear Pharmacy Settings Author(s): Weatherman Kara D, Augustine Samuel, Christoff Jeffrey, Galbraith Wendy
Jan/Feb 2013 Pg. 54-60	Basics of Compounding: Repackaging, Part 1 Author(s): Allen Loyd V Jr
Jan/Feb 2013 Pg. 64	Desmopressin 4-mcg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2013 Pg. 65	Dobutamine 10-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2013 Pg. 66	Granisetron 1-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2013 Pg. 67	Ibuprofen 10-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2013 Pg. 68	Mepivacaine Hydrochloride 1% Injection Author(s): Allen Loyd V Jr
Jan/Feb 2013 Pg. 69	Milrinone 0.2-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2013 Pg. 70	Neostigmine Methylsulfate 0.5-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2013 Pg. 71	Nicardipine Hydrochloride Injection Author(s): Allen Loyd V Jr
Jan/Feb 2013 Pg. 72	Octreotide 50-mcg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2013 Pg. 73	Testosterone Cypionate 100-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2012 Pg. 500	Aminophylline 25-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2012 Pg. 501	Ammonium Chloride 5-mEq/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2012 Pg. 502	Azathioprine 10-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2012 Pg. 503	Copper 0.4-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2012 Pg. 504	Dipyridamole 5-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2012 Pg. 505	Dopamine Hydrochloride 80-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2012 Pg. 506	Ergotamine Tartrate 1-mg and Caffeine 100-mg Capsules Author(s): Allen Loyd V Jr
Nov/Dec 2012 Pg. 507	Papaverine Hydrochloride 30-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2012 Pg. 508	Valproate Sodium 100-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2012 Pg. 509	Vercuronium Bromide 1-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2012 Pg. 425	Metronidazole 5-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2012 Pg. 418	Doxapram Hydrochloride 20-mg/mL injection Author(s): Allen Loyd V Jr
Sep/Oct 2012 Pg. 419	Enalaprilat 1.25-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2012 Pg. 420	Esmolol Hydrochloride 10-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2012 Pg. 421	Fluconazole 2-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2012 Pg. 422	Haloperidol 50-mg/mL in Oil Injection Author(s): Allen Loyd V Jr
Sep/Oct 2012 Pg. 423	Meperidine Hydrochloride 50-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2012 Pg. 424	Methocarbamol 100-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2012 Pg. 426	Nalbuphine Hydrochloride 10-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2012 Pg. 427	Oxymorphone Hydrochloride 1-mg/mL Injection Author(s): Allen Loyd V Jr
May/Jun 2012 Pg. 190-195	I See Colors: Using Vital Dyes in Diagnosing Ophthalmic Disease Author(s): McElhiney Linda F
Jan/Feb 2012 Pg. 86-87	PostScription: Best Practice Recommendations for Compounding 17-Hydroxyprogesterone Author(s): Cabaleiro Joe
Jan/Feb 2012 Pg. 6-10	Misinterpretation of United States Pharmacopeia Chapter <797> Author(s): McElhiney Linda F
Sep/Oct 2011 Pg. 390-407	Quality-Control Analytical Methods: Aqua Pura: Water Purification Systems and United States Pharmacopeia Waters for the Compounding Pharmacy, Part 3: Testimonials and Comparisons Author(s): James Kate, Allred Richard, Latta Kenneth S, McElhiney Linda F, Olson Jacob, Hall Richard M, Baker Chad, Armstrong Nicholas, Janik Peter, Whitehead Paul, Purcell Julian
May/Jun 2011 Pg. 224-232	Quality Control Analytical Methods: Aqua Pura: Water Purification Systems and United States Pharmacopeia Waters for the Compounding Pharmacy, Part 2: USP Waters: Experts at the United States Pharmacopeia Answer Compounders' Questions Author(s): Schnatz Rick, Hernandex-Cardoso Antonio
Mar/Apr 2011 Pg. 133-144	Quality Control Analytical Methods: Aqua Pura: Water Purification Systems and United States Pharmacopeia Waters for the Compounding Pharmacy, Part 1 Author(s): Latta Kenneth S, Cabaleiro Joe, Whitehead Paul, Edison Doug
Jan/Feb 2011 Pg. 4	PreScription: The Resources of the International Journal of Pharmaceutical Compounding, Inc.; Sterile Compounding Meets Needs for Patients, Professionals Author(s): Allen Loyd V Jr, Menighan Thomas E
Jan/Feb 2011 Pg. 20-26	A Technology Guide for Evaluating Software Tools to Support Sterile Compounding and Workflow Management Author(s): Robinson Marian
Jan/Feb 2011 Pg. 49-54	Quality-Control Analytical Methods: Endotoxins: Essential Testing for Pyrogens in the Compounding Laboratory, Part 3: A Simplified Endotoxin Test Method for Compounded Sterile Preparations Author(s): Cooper James F
Nov/Dec 2010 Pg. 493-506	Quality-Control Analytical Methods: Endotoxins: Essential Testing for Pyrogens in the Compounding Laboratory, Part 2 Author(s): Cooper James F, Chakrabarty Kaushik, McGuire Jason, Zolner William J, Jones Vann, Hedman Hilary
Nov/Dec 2010 Pg. 450-455	Home Infusion: Overcoming the Barriers to Entry Author(s): Franklin David M
Sep/Oct 2010 Pg. 370-372	Implementation of a Viable Air-Sampling Program Using a Volumetric Collection Device Author(s): Kennedy Steve, Siefert Lisa Linn, Lange Matt
Sep/Oct 2010 Pg. 407-414	Quality Control Analytical Methods: Endotoxins: Essential Testing for Pyrogens in the Compounding Laboratory, Part 1 Author(s): Dubczak John, Latta Kenneth S, Hedman Hilary, Smith Donald R
Sep/Oct 2010 Pg. 440-441	PostScription: Guidance to Achieve Accreditation from the Pharmacy Compounding Accreditation Board Author(s): Pharmacy Compounding Accreditation Board
Jul/Aug 2010 Pg. 268	PreScription: Sterile Product Outsourcing: Growing Trend in Hospitals Author(s): Menighan Thomas E
Jul/Aug 2010 Pg. 270-274	Developing an Erythromycin Ophthalmic Ointment: Putting the Puzzle Pieces Together Author(s): McElhiney Linda F
Jul/Aug 2010 Pg. 317-320	Quality Control Analytical Methods: Pharmacopeial Bacterial Endotoxins Test Chapters Author(s): Dawson Michael E
Jul/Aug 2010 Pg. 328-331	Basics of Compounding: Considerations for Implementing USP Chapter <797> Pharmacy Compounding -- Sterile Preparations, Part 20: Patient or Caregiver Training, Patient Monitoring and Adverse Events Reporting, and Quality-Assurance Program Author(s): Okeke Claudia C, Allen Loyd V Jr
May/Jun 2010 Pg. 232-238	Basics of Compounding: Considerations for Implementing USP Chapter <797> -- Sterile Preparations, Part 19: Storage and Beyond-Use Dating, Maintaining Sterility, Purity, and Stability of Dispensed and Distributed Compounded Sterile Preparations Author(s): Okeke Claudia C, Allen Loyd V Jr
Mar/Apr 2010 Pg. 142-149	Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 18: Verification of Automated Compounding Devices for Parenteral Nutrition Compounding and Finished Preparation Release Checks and Tests Author(s): Allen Loyd V Jr, Okeke Claudia C
Mar/Apr 2010 Pg. 160-164	Chemical Stability of Hydromorphone Hydrochloride in Patient-Controlled Analgesia Injector Author(s): Khondkar Dristi, Chopra Poonam, McArter John P, Rosen Joseph A, Li S Kevin
Jan/Feb 2010 Pg. 70	Ophthalmic Toning-Lubricating Drops Author(s): Allen Loyd V Jr
Jan/Feb 2010 Pg. 48-53	An Academic Practice Partnership: An Innovative Course in Advanced Compounding Author(s): Hale Katherine S, Hammer Dana P, Needham Shawn, Lawhorn Michelle Gaster
Jan/Feb 2010 Pg. 60-64	Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmacy Compounding Sterile Preparations, Part 17: Elements of Quality Control Author(s): Okeke Claudia C, Allen Loyd V Jr
Nov/Dec 2009 Pg. 506-515	Autologous Eye Drops for the Treatment of Dry Eye and Neurotrophic Keratitis Author(s): Mixon William, Angelle Patricea (Patsy), Chang Richard I
Nov/Dec 2009 Pg. 540-543	Quality-Control Analytical Methods: Applications and Sterility of Autologous Eye Drops Author(s): Reed-Kane Dana, Carlson Rachel A, Kupiec Thomas C, Vu Nicole
Nov/Dec 2009 Pg. 546-553	Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 16: Suggested Standard Operating Procedures Author(s): Okeke Claudia C, Allen Loyd V Jr
Nov/Dec 2009 Pg. 564-568	Stability of Preoperative Cataract Surgery Gel in Polycarbonate Syringes Author(s): Bailey Caroline, Aloumanis Vasileios, Walker Brian, Ben Michel, McGuire Jason, Vu Nicole
Sep/Oct 2009 Pg. 420-426	Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chater <797> Pharmaceutical Compounding--Sterile Preparations, Part 15: Personnel Training, Cleansing, and Garbing Author(s): Okeke Claudia C, Allen Loyd V Jr
Jul/Aug 2009 Pg. 290-294	Preventing Nonmicrobiologic Airborne Contamination in the Compounding Pharmacy: Ensuring a Safe Environment for Compounders, Staff, and Clients Author(s): Mixon Bill, Ille Gary
Jul/Aug 2009 Pg. 322-329	Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 14: Environmental Quality and Control (Continued) Author(s): Okeke Claudia C, Allen Loyd V Jr
Jul/Aug 2009 Pg. 350-351	PostScription: Compounding Pharmacy in Puerto Rico Author(s): Lopez Marisol
Jul/Aug 2009 Pg. 300-310	Preparing Nonsterile and Sterile Hazardous Compounds in an Institutional Setting Author(s): McElhiney Linda F
May/Jun 2009 Pg. 234-238	Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 13: Environmental Quality and Control Author(s): Allen Loyd V Jr, Okeke Claudia C
Mar/Apr 2009 Pg. 94-98	Compliance by Hospitals and Healthcare Facilities with the Revised United States Pharmacopeia Chapter <797> Author(s): McElhiney Linda F
Mar/Apr 2009 Pg. 100-104	Tips for Cleanroom Construction and Renovation Author(s): Mixon William, Huffman Lanny
Mar/Apr 2009 Pg. 106-119	Contract Sterilization and Validation Companies Offer New Options for Sterile Compounded Preparations Author(s): Latta Kenneth S, Howard Betty, Gordon Ken, Foster Lisa, Nichols Larry, Floyd Dan B, Winters Martell, Bryans Trabue
Mar/Apr 2009 Pg. 146-150	Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 12: Sterilization Methods Author(s): Allen Loyd V Jr, Okeke Claudia C
Mar/Apr 2009 Pg. 152	Acidified Sodium Hypochlorite for Antisepsis and Disinfection Author(s): Allen Loyd V Jr
Jan/Feb 2009 Pg. 53-55	Quality Control Analytical Methods: Testing of Electrolytes Solutions Author(s): Vu Nicole
Jan/Feb 2009 Pg. 56-62	Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 11: Hazardous Drugs Author(s): Allen Loyd V Jr, Okeke Claudia C
Sep/Oct 2008 Pg. 440-443	Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 9: Immediate-Use Compounded Sterile Preparations Author(s): Allen Loyd V Jr, Okeke Claudia C
Nov/Dec 2008 Pg. 524-528	Quality-Control Analytical Methods: Overview of Beyond-Use Dating for Compounded Sterile Preparations Author(s): Trissel Lawrence A
Nov/Dec 2008 Pg. 542	Glycerin, Sterile Author(s): Allen Loyd V Jr
Nov/Dec 2008 Pg. 530-536	Basics of Compounding: United States Pharmacopeia General Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 10: First Revision: The Main Changes, Events, and Rationale Author(s): Okeke Claudia C, Newton David W, Kastango Eric S, Allen Loyd V Jr
Jul/Aug 2008 Pg. 344-353	Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 8; Stability and Beyond-Use Dating Author(s): Allen Loyd V Jr, Okeke Claudia C
Jul/Aug 2008 Pg. 321-327	Microbial Air-Sampling Equipment, Part 2: Experiences of Compounding Pharmacists Author(s): Mixon Bill, Cabaleiro Joe, Latta Kenneth S, Vail Jane
May/Jun 2008 Pg. 252-257	Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 7: Microbial Contamination Risk Levels, 12-Hour Use, and Immediate Use Author(s): Allen Loyd V Jr, Okeke Claudia C
May/Jun 2008 Pg. 216-229	Microbial Air-Sampling Equipment, Part 1: Meeting United States Pharmacopeia Chapter <797> Standards Author(s): Kastango Eric S
May/Jun 2008 Pg. 200-207	Dilution and Compounding of Ziconotide for Intrathecal Administration Author(s): Buchta Tony, Fakata Keri, Stuart William
Mar/Apr 2008 Pg. 130-135	Quality-Control Analytical Methods: Minimizing the Probability of Out-of-Specification Preparations: Results that Make You Say…Hmmm! Author(s): Odegard Russell D
Mar/Apr 2008 Pg. 136-144	Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 6: 2008 Revisions to Chapter <797> Author(s): Allen Loyd V Jr, Okeke Claudia C
Jan/Feb 2008 Pg. 54-60	Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 5: Verification of Accuracy, Sterility, and Sterilization of Compounded Preparations Author(s): Allen Loyd V Jr, Okeke Claudia C
Nov/Dec 2007 Pg. 450-470	Achievement of USP Chapter <797> Compliance by a 35-Bed Rural Hospital: A Case Study Author(s): Peters Gregory F, McKeon Marghi R, Nerbun Richard G
Nov/Dec 2007 Pg. 492-499	Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 4: Considerations in Selection and Use of Disinfectants and Antiseptics Author(s): Allen Loyd V Jr, Okeke Claudia C
Nov/Dec 2007 Pg. 500-501	Calculations: High-Technology Compounding and Investigational Dispensing Author(s): Webb Sheldon D, Stockton Shelly J
Nov/Dec 2007 Pg. 502-503	Standard Operating Procedure: Vial Crimper--Use, Care, Cleaning, and Maintenance Author(s): Allen Loyd V Jr
Sep/Oct 2007 Pg. 400-403	Quality-Control Analytical Methods: A Discussion of United States Pharmacopeia Chapter <71> Sterility Tests Author(s): Kupiec Thomas C
Sep/Oct 2007 Pg. 404-410	Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 3: Risk Levels Author(s): Allen Loyd V Jr, Okeke Claudia C
Jul/Aug 2007 Pg. 328	Fentanyl 50-mg/mL in 0.9% Sodium Chloride Solution Author(s): Allen Loyd V Jr
Jul/Aug 2007 Pg. 302-305	Update on the Proposed Revision Process for United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations Author(s): Okeke Claudia C
Jul/Aug 2007 Pg. 314-323	Basics of Compounding: The Responsibilities of Compounding Personnel in Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 2 Author(s): Allen Loyd V Jr, Okeke Claudia C
Jul/Aug 2007 Pg. 335	Sufentanil 50-mg/mL in 0.9% Sodium Chloride Solution Author(s): Allen Loyd V Jr
May/Jun 2007 Pg. 230-236	Basics of Compounding for the Implementation of United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 1 Author(s): Allen Loyd V Jr, Okeke Claudia C
Jan/Feb 2007 Pg. 52-55	Quality Control Analytical Methods: The Quality of Sterility Testing Author(s): McGuire Jason, Kupiec Thomas C
Nov/Dec 2006 Pg. 428-433	BioBullet: Innovative Pharmaceutical Compounding for Treating Cattle Author(s): Benischek Rita L
Sep/Oct 2006 Pg. 372-375	Quality-Control Analytical Methods: Sterility Failure Investigations Author(s): Venti Eden M
Jul/Aug 2006 Pg. 277-280	Teaching Lab Renovation: University of Texas at Austin College of Pharmacy Combines Sterile and Nonsterile Compounding Lab Spaces Author(s): Acosta W Renee, Salzman Robert D
Jul/Aug 2006 Pg. 281-284	Quality Control Analytical Methods: A Guide to Quality Control Testing for the Compounding Pharmacist Author(s): Zolner William J
Jul/Aug 2006 Pg. 293-295	Aseptic Compounding in New Zealand and the Use of Still Air Boxes Author(s): Gargiulo Derryn, Kairuz Therese Eileen
Jul/Aug 2006 Pg. 253-261	Training and Competency Considerations for Pharmacies Providing Compounded Sterile Preparations Author(s): Douglass Kate
Jul/Aug 2006 Pg. 263-268	Putting the Science Back into the "Art and Science" of Compounding Author(s): Kastango Eric S
May/Jun 2006 Pg. 165-171	Prevention of Preterm Delivery with Compounded 17a-Hydroxyprogesterone Caproate Author(s): Reed-Kane Dana, Kirshbaum Karen
May/Jun 2006 Pg. 172	Case Report: Hydroxyprogesterone Caproate Injection for Prevention of Preterm Labor Author(s): Fields Shannon W
May/Jun 2006 Pg. 202-204	Quality-Control Analytical Methods: Particulate Matter in Injections: What is It and What are the Concerns? Author(s): Tran Tuan, Kupiec Thomas C, Trissel Lawrence A
May/Jun 2006 Pg. 218	Standard Operating Procedure: Sterility Test for Ophthalmic Solutions Author(s): Allen Loyd V Jr
May/Jun 2006 Pg. 208-211	Controlled Environment Testing Association Applications Guide for the Use of Barrier Isolators in Compounding Sterile Preparations in Healthcare Facilities, Part 2 Author(s): Wagner James T
Mar/Apr 2006 Pg. 113-119	Is Your Cleanroom Clean? An In-depth Look at Cleaning and Disinfecting Agents, Procedures, and Requirements for the Compounding Pharmacist Author(s): Jeffrey Megan
Jan/Feb 2006 Pg. 36-39	Basics of Compounding: Application of the United States Pharmacopeia Bacterial Endotoxins Test to Compounded Sterile Preparations Author(s): Dawson Michael F
Jan/Feb 2006 Pg. 46-49	How'd They Do That? Author(s): Roberts Jerrod L
Jan/Feb 2006 Pg. 69-73	Stability of Morphine Sulfate in Polypropylene Infusion Bags for Use in Patient-Controlled Analgesia Pumps for Postoperative Pain Management Author(s): Nguyen-Xuan Tho, Griffiths William, Kern Christian, Van Gessel Elisabeth, Bonnabry Pascal
Sep/Oct 2005 Pg. 390	Meperidine Hydrochloride 50-mg and Atropine Sulfate 0.4-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2005 Pg. 394	Morphine Sulfate 16-mg and Atropine Sulfate 0.4-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2005 Pg. 395	Morphine Sulfate 5-mg/mL PCA Injection (Concentration May Vary) Author(s): Allen Loyd V Jr
Mar/Apr 2005 Pg. 127-130	Proposed Revisions to USP Chapter <797> Pharmaceutical Compounding--Sterile Preparations Author(s): Newton David W
Mar/Apr 2005 Pg. 167	PostScription: Experts Everywhere Author(s): Rahe Hank
Jan/Feb 2005 Pg. 11-13	USP Chapter <797>: Practical Solutions for Microbiology, Sterility, and Pyrogen Testing Author(s): Caputo Ross A, Huffman Anne, Reich Robert
Jan/Feb 2005 Pg. 15-21	Using ACDs in the Practice of Pharmacy Author(s): Kastango Eric S
Jan/Feb 2005 Pg. 23-28	USP Chapter <797> and Preparing for a JCAHO Survey Author(s): McElhiney Linda F
Jan/Feb 2005 Pg. 29-31	Questions and Answers: USP Chapter <797> and JCAHO Compliance Author(s): Allen Loyd V Jr
Jan/Feb 2005 Pg. 33-35	A Dialogue Concerning Contamination Control Systems: Where Does the Isolator Fit In? Author(s): Vandenbroucke Johan, Rahe Hank
Jan/Feb 2005 Pg. 47-49	Quality-Control Analytical Methods: Microbial Testing Aspects of USP <797> for Compounded Sterile Preparations Author(s): Kupiec Thomas C
Jan/Feb 2005 Pg. 53-56	Barrier Isolators, Isolators, and Glove Boxes--What's the Difference? Author(s): Rahe Hank
Nov/Dec 2004 Pg. 466-467	Standard Operating Procedure: Calculating the Endotoxin Load in Compounded Sterile Preparations Author(s): Allen Loyd V Jr
Nov/Dec 2004 Pg. 468	Calculations Author(s): Prince Shelly J
Nov/Dec 2004 Pg. 479-485	Quality-Control Analytical Methods: Allowable Endotoxic Levels in Sterile Preparations Author(s): Allen Loyd V Jr
Sep/Oct 2004 Pg. 393-397	Quality-Control Analytical Methods: USP Chapter <797> Compounded Sterile Preparations Sterility Requirements and Their Relationship to Beyond-Use Dating Author(s): Kastango Eric S
Jul/Aug 2004 Pg. 242	PreScription - Categories of Pharmaceutial Compounding Author(s): Allen Loyd V Jr
Jul/Aug 2004 Pg. 251-263	A Primer on USP Chapter 797, "Pharmaceutical Compounding - Sterile Preparations," and USP Process for Drug and Practice Standards Author(s): Newton David W, Trissel Lawrence A
May/Jun 2004 Pg. 216	Clonidine HCl 1.5-mg/mL Injection Author(s): Allen Loyd V Jr
May/Jun 2004 Pg. 217	Fluorouracil 1% Ophthalmic Solution Author(s): Allen Loyd V Jr
May/Jun 2004 Pg. 220	Morphine Sulfate 25-mg/mL and Ketamine HCl 25-mg/mL Injection Author(s): Allen Loyd V Jr
May/Jun 2004 Pg. 222	Testosterone Propionate 100-mg/mL in Oil Injection Author(s): Allen Loyd V Jr
May/Jun 2004 Pg. 228-230	Physical and Chemical Stability of Trepostinil Sodium Injection Packaged in Plastic Syringe Pump Reservoirs. Author(s): Xu Quanyun A, Trissel Lawrence A, Pham Lien
May/Jun 2004 Pg. 231-235	Long-Term Stability of Trimix: A Three-Drug Injection Used to Treat Erectile Dysfunction. Author(s): Trissel Lawrence A, Zhang Yanping
May/Jun 2004 Pg. 236-239	Stability of Zidovudine and Ranitidine in 0.9% sodium Chloride and 5% Dextrose Injections Stored at Ambient Temperature (23 ± 2°C) and 4°C in 50-mL Polyvinylchloride Bags Up to 24 Hours. Author(s): Musami Patrick, Stewart James T, Taylor E Will
Mar/Apr 2004 Pg. 89-94	Overview of Chapter <797> "Pharmaceutical Compounding - Sterile Preparations": The Potential Impact for Compounding Pharmacists Author(s): Rahe Hank
Mar/Apr 2004 Pg. 138	Netilmicin 0.455% Ophthalmic Solution Author(s): Allen Loyd V Jr
Mar/Apr 2004 Pg. 139	Pyridoxine HCl 100-mg/mL Injection, Preservative Free Author(s): Allen Loyd V Jr
Mar/Apr 2004 Pg. 153-155	Chemical Stability of Phenylephrine HCl After Reconstitution in 0.9% Sodium Chloride Injection for Infusion Author(s): Gupta Vishnu D
Mar/Apr 2004 Pg. 156-159	Effect of Freezing, Long-Term Storage and Microwave Thawing on the Stability of Tramadol in 5% Dextrose Infusion in Polyvinyl Chloride Bags Author(s): Lebrun John, Hecq Jean-Daniel, Vanbeckbergen Danielle, Jamart Jacques, Galanti Laurence M
Mar/Apr 2004 Pg. 160	PostScription: Cleanroom Standards Author(s): Fitzpatrick Mike, Goldstein Ken
Jan/Feb 2004 Pg. 54	Glycerin 50% Injection Author(s): Allen Loyd V Jr
Jan/Feb 2004 Pg. 55	Hydrochloric Acid 0.1-N Injection Author(s): Allen Loyd V Jr
Jan/Feb 2004 Pg. 57	Phenol 5%-in-Oil Injection Author(s): Allen Loyd V Jr
Jan/Feb 2004 Pg. 60	Vancomycin HCl and Heparin Sodium Injection Author(s): Allen Loyd V Jr
Jan/Feb 2004 Pg. 73-76	Stability of Zidovudine and Dobutamine HCl Injections in 0.9% Sodium Chloride and 5% Dextrose Injections Stored at Ambient Temperature (23 ± 2°C) and 4°C in 50-mL Polyvinyl Chloride Bags Up to 24 Hours Author(s): Musami Patrick, Stewart James T, Taylor E Will
Jul/Aug 2003 Pg. 281-285	Containment of Hazardous Particulates in the Compounding Pharmacy Author(s): Allen Loyd V Jr
May/Jun 2003 Pg. 230-232	Stability of Amikacin Sulfate in AutoDose Infusion System Bags Author(s): Zhang Yanping, Trissel Lawrence A
Mar/Apr 2003 Pg. 114-116	Autoclaves for the Sterilization of Compounded Parenteral Products Author(s): Rahe Hank
Jan/Feb 2003 Pg. 42-43	Technology Spotlight: Barrier Isolators Author(s): Moussa Magdy, Rahe Hank, Lo Katharine
Nov/Dec 2002 Pg. 408-409 View Sample	Comparison of Endotoxin Testing Methods for Pharmaceutical Products Author(s): Joiner Timothy J, Kraus Paul F, Kupiec Thomas C
Nov/Dec 2002 Pg. 414	Book Review: Sterile Compounding Author(s): Reed-Kane Dana
Nov/Dec 2002 Pg. 415-417	Sterile Compounding of Respiratory Inhalation Solutions Author(s): Roberts Rob, Moore Eddie
Nov/Dec 2002 Pg. 448	Benzalkonium Chloride 1:750 Solution for Cold Disinfection Author(s): Allen Loyd V Jr
Nov/Dec 2002 Pg. 453	Furosemide 10-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2002 Pg. 457	Phenobarbital Sodium 130-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2002 Pg. 466-467	Cleaning and Disinfection Author(s): Allen Loyd V Jr
Mar/Apr 2002 Pg. 140-141	Sterilization of Talc for Use in Pleurodesis Author(s): Fehr Richard, Henke Michelle, Ashworth Lisa D
Jan/Feb 2002 Pg. 55-57	New Perspectives on Vancomycin Use in Home Care, Part 2: Delivery Systems Author(s): Kastango Eric S, Hadaway Lynn
Nov/Dec 2001 Pg. 422-423	Barrier Isolators: A New, High-tech Option for the Preparation of Sterile Admixtures Author(s): Karolchyk Scott
Nov/Dec 2001 Pg. 455	Sufentanil 25-mcg/mL, Bupivacaine 1-mg/mL Intrathecal Solution Author(s): Allen Loyd V Jr
Nov/Dec 2001 Pg. 465-469	New Perspectives on Vancomycin Use in Home Care, Part 1 Author(s): Kastango Eric S, Hadaway Lynn
Nov/Dec 2001 Pg. 476-479	Cross-contamination in Porcelain Mortars Author(s): Bauer-Brandl Annette, Falck Astrid, Ingebrigtsen Lars, Nilsen Cathrina
Jul/Aug 2001 Pg. 246-253	Quality Assurance for Sterile Products Author(s): Kastango Eric S, Douglass Kate
Jul/Aug 2001 Pg. 254-258	Sterile Compounding with Barrier-Isolation Technology Author(s): Rahe Hank
Jul/Aug 2001 Pg. 259-263	Bacterial Endotoxins and Pyrogens Author(s): Jones Marty
Jul/Aug 2001 Pg. 265-267	Evolution of the United States Pharmacopeia Chapter <1206>: "Sterile Preparations - Pharmacy Practices" Author(s): Okeke Claudia C, Barletta Frank, Newton David W, Allen Loyd V Jr
Jul/Aug 2001 Pg. 278-279	Sterile Compounding: Excerpts from the Reviews of Current Published Literature Author(s): MacCara Mary E
Jul/Aug 2001 Pg. 284-286	Analytical Testing Facilities and Products Author(s): Hudson Sonora
Jul/Aug 2001 Pg. 313	Maintenance of the Cleanroom Author(s): Allen Loyd V Jr
Jan/Feb 2001 Pg. 59-63	Sterile-Product Preparations: Mix or Buy? Author(s): Kastango Eric S
Jul/Aug 2000 Pg. 280	Short Communication: Compounding for Implantable Pumps Author(s): Molitor Richard
May/Jun 2000 Pg. 223-224	Dry Heat Sterilization of Parenteral Oil Vehicles Author(s): Kupiec Thomas C, Matthews Parrish, Ahmad Riaz
Jan/Feb 2000 Pg. 24-25	Compounding Intrathecal Medications Author(s): Vidrine Eric
Sep/Oct 1999 Pg. 406-407	Standard Operating Procedure: Quality Assessment for Injectable Solutions Author(s): Allen Loyd V Jr
Jul/Aug 1999 Pg. 253-258	Improving the Management, Operations and Cost Effectiveness of Sterile-Product Compounding Author(s): Kastango Eric S, Douglass Kate
Jul/Aug 1999 Pg. 263-269	Sterilization and Depyrogenation Principles and Methods Author(s): Akers Michael J
Jul/Aug 1999 Pg. 270-273	Sterile Product Compounding: A Comparison of ASHP and USP Guidelines Author(s): Lima Hetty A
Jan/Feb 1999 Pg. 64-66	Y-Site Stability of Fosphenytoin and Sodium Phenobarbital Author(s): English Brett A, Riggs Robert M, Webster Andrew A, Benner Kimberly W
Sep/Oct 1998 Pg. 379	Testing for Bacterial Endotoxins Author(s): Jelinek Todd
May/Jun 1998 Pg. 189	Ophthalmic Compounding: Techniques for Achieving Sterility Author(s): Leiter Charles W
May/Jun 1998 Pg. 192-195	Preservation, Sterilization, and Sterility Testing of Ophthalmic Preparations Author(s): Allen Loyd V Jr
May/Jun 1998 Pg. 214-215	An Automated Process for Batch Preparation of Epidural Solutions Containing Bupivacaine Hydrochloride and Fentanyl Citrate Author(s): Rice Stephen P
May/Jun 1998 Pg. 242	General Aseptic Procedures Used at a Laminar Airflow Workbench Author(s): Allen Loyd V Jr